Cargando…

Durable response to olaparib in pancreatic duct adenocarcinoma with deleterious ARID1A mutation

Detalles Bibliográficos
Autores principales: Zhao, Xue-Song, Zhou, Jing, Dong, Lei, Zhang, Hui, Ye, Ying-Jiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6964940/
https://www.ncbi.nlm.nih.gov/pubmed/31764178
http://dx.doi.org/10.1097/CM9.0000000000000550
_version_ 1783488555015733248
author Zhao, Xue-Song
Zhou, Jing
Dong, Lei
Zhang, Hui
Ye, Ying-Jiang
author_facet Zhao, Xue-Song
Zhou, Jing
Dong, Lei
Zhang, Hui
Ye, Ying-Jiang
author_sort Zhao, Xue-Song
collection PubMed
description
format Online
Article
Text
id pubmed-6964940
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-69649402020-02-10 Durable response to olaparib in pancreatic duct adenocarcinoma with deleterious ARID1A mutation Zhao, Xue-Song Zhou, Jing Dong, Lei Zhang, Hui Ye, Ying-Jiang Chin Med J (Engl) Correspondence Wolters Kluwer Health 2019-12-20 2019-12-20 /pmc/articles/PMC6964940/ /pubmed/31764178 http://dx.doi.org/10.1097/CM9.0000000000000550 Text en Copyright © 2019 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0
spellingShingle Correspondence
Zhao, Xue-Song
Zhou, Jing
Dong, Lei
Zhang, Hui
Ye, Ying-Jiang
Durable response to olaparib in pancreatic duct adenocarcinoma with deleterious ARID1A mutation
title Durable response to olaparib in pancreatic duct adenocarcinoma with deleterious ARID1A mutation
title_full Durable response to olaparib in pancreatic duct adenocarcinoma with deleterious ARID1A mutation
title_fullStr Durable response to olaparib in pancreatic duct adenocarcinoma with deleterious ARID1A mutation
title_full_unstemmed Durable response to olaparib in pancreatic duct adenocarcinoma with deleterious ARID1A mutation
title_short Durable response to olaparib in pancreatic duct adenocarcinoma with deleterious ARID1A mutation
title_sort durable response to olaparib in pancreatic duct adenocarcinoma with deleterious arid1a mutation
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6964940/
https://www.ncbi.nlm.nih.gov/pubmed/31764178
http://dx.doi.org/10.1097/CM9.0000000000000550
work_keys_str_mv AT zhaoxuesong durableresponsetoolaparibinpancreaticductadenocarcinomawithdeleteriousarid1amutation
AT zhoujing durableresponsetoolaparibinpancreaticductadenocarcinomawithdeleteriousarid1amutation
AT donglei durableresponsetoolaparibinpancreaticductadenocarcinomawithdeleteriousarid1amutation
AT zhanghui durableresponsetoolaparibinpancreaticductadenocarcinomawithdeleteriousarid1amutation
AT yeyingjiang durableresponsetoolaparibinpancreaticductadenocarcinomawithdeleteriousarid1amutation